Med-tech giant Medtronic posted another quarter of weaker sales and earnings on Tuesday, a reflection of the continued slowdown of health care procedures unrelated to the Covid-19 pandemic. But the company said it's seeing signs of improvement, and its financial performance still beat Wall Street estimates.